Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children

Author： Kociancic Todd   Reed Michael D   Findling Robert L  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.2, 2004-03, pp. : 93-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep

By  

Current Pharmaceutical Design, Vol. 17, Iss. 15, 2011-05 ,pp. : 1450-1458

Bentham Science Publishers

Access to resources Recommend Favorite

Atomoxetine: long-term treatment benefits in ADHD

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Long-Term Stimulant Effects in Children with Attention Deficit Hyperactivity Disorder (ADHD)

By  

Child and Adolescent Psychopharmacology News, Vol. 9, Iss. 1, 2004-02 ,pp. : 1-12

Guilford Publications Inc

Access to resources Recommend Favorite

Long-term warfarin treatment may be associated with decreased BMD in children with congenital heart disease

By  

Reactions Weekly, Vol. 1, Iss. 1051, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Long-term drug therapy plays an important part in the holistic treatment of chronic constipation in children

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 12, 2007-12 ,pp. : 16-19

Adis International

Access to resources Recommend Favorite